AB053. P-21. M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): efficacy by BTC subtype

BACKGROUND: Biliary tract cancers (BTCs) are a group of cancers with poor prognosis and few treatment options. For 2L chemotherapy, no standard-of-care therapy exists, and overall response rates ORRs) are <10%. M7824 is an innovative first-in-class bifunctional fusion protein composed of 2 extrac...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Hepatobiliary Surg Nutr
Κύριοι συγγραφείς: Yoo, Changhoon, Oh, Do-Youn, Choi, Hye Jin, Kudo, Masatoshi, Ueno, Makoto, Kondo, Shunsuke, Chen, Li-Tzong, Osada, Motonobu, Helwig, Christoph, Dussault, Isabelle, Ikeda, Masafumi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: AME Publishing Company 2019
Θέματα:
Poster Abstracts
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421177/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB053
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια